Emalex Biosciences
0 followers
Emalex Biosciences, LLC is a biopharmaceutical company dedicated to the development of new treatments for rare and orphan neurological conditions. Ecopipam, its first development candidate, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disor... Read more
Org chart
Eric Messner
CEO
Eric Messner
Collapse
Frederick Munschauer
Chief Medical Officer, Neurology & SVP, Medical, Scientific Affairs
Doug Frandsen
Corporate Comptroller
Paul Reinfelds
SVP, Legal Affairs & General Counsel
Jay White
VP, Chemistry, Manufacturing and Controls
Sarah Atkinson
VP, Clinical Development
Jenny Swalec
VP, Regulatory Affairs & Quality Assurance
Trish Rice
VP, Biostatistics & Data Management
Jose Zapata
AVP, Quality Assurance
Tom Stothoff
Senior Director, Chemistry, Manufacturing & Controls Regulatory Affairs
Christine H. Soulje
Senior Director, Product Development
